Investigator-initiated, multi-center, single-arm, open-label study of the effectiveness of canakinumab in Japanese patients with Schnitzler syndrome.
Kambe N, Yamamoto M, Takemura K, Kagami SI, Kawahara Y, Yoshifuji H, Jo T, Izawa K, Nakamizo S, Inoue N, Ito T, Amino Y, Ibi Y, Morita S, Kanazawa N.
Kambe N, et al. Among authors: inoue n.
Allergol Int. 2024 Dec 16:S1323-8930(24)00117-5. doi: 10.1016/j.alit.2024.10.001. Online ahead of print.
Allergol Int. 2024.
PMID: 39690084
Free article.